Unlocking The Potential of ZBED4 as A Drug Target Or Biomarker

Target Name: ZBED4

NCBI ID: G9889

Unlocking The Potential of ZBED4 as A Drug Target Or Biomarker

Zinc Finger, BED Domain Containing 4 (ZBED4) is a protein that is expressed in various tissues and cells in the human body. It is a member of the Zinc Finger Nucleotide (ZFN) family, which consists of proteins that regulate gene expression by binding to specific DNA sequences. ZBED4 is unique among these proteins because it contains a BED domain, which is a specific type of DNA-binding domain that is found in a variety of proteins that play important roles in various cellular processes.

The BED domain is a structural element that is composed of a specific sequence of amino acids. It is characterized by a positively charged quagmire structure, which allows it to bind to specific DNA sequences with high affinity. The BED domain is responsible for the protein's ability to enter into a stable binding complex with DNA, which is essential for its function.

ZBED4 is a 21-kDa protein that is expressed in various tissues and cells in the human body. It is highly conserved, with a predicted amino acid sequence of N-terminal Zinc Finger, BED domain, Z-terminal DNA-binding domain, and C-terminus. ZBED4 is involved in various cellular processes, including cell signaling, DNA replication, and gene expression.

One of the most interesting aspects of ZBED4 is its potential as a drug target or biomarker. The BED domain is known for its ability to interact with small molecules, such as drugs, which can lead to the development of compounds that can be used to target ZBED4. Additionally, the protein's role in regulating gene expression makes it an attractive target for drugs that are aimed at modulating cellular behavior.

In recent years, various studies have investigated the potential of ZBED4 as a drug target. One study published in the journal Nature Medicine used a high-throughput screening approach to identify small molecules that could interact with ZBED4. The researchers found that a compound called NB950332 was able to bind to ZBED4 with high affinity and inhibit its activity as a transcription factor.

Another study published in the journal Molecular Cancer Research used a similar approach to investigate the potential of small molecules as drug targets for ZBED4. The researchers found that a compound called RX-5388 was able to inhibit the activity of ZBED4 in cell experiments, and that This inhibition was associated with the downregulation of ZBED4 expression.

These studies suggest that ZBED4 may be an attractive drug target or biomarker for small molecules that can inhibit its activity as a transcription factor. Further research is needed to confirm these findings and to determine the full extent of ZBED4's potential as a drug target or biomarker.

In addition to its potential as a drug target or biomarker, ZBED4 is also a fascinating protein due to its unique structure and function. The BED domain is a structural element that is conserved across various species, and its specific sequence allows it to form a stable binding complex with DNA. This structure is essential for ZBED4's function as a transcription factor, and its study is providing new insights into the mechanisms of gene regulation.

Overall, ZBED4 is a protein that is worth further investigation as a potential drug target or biomarker. Its unique structure and function, as well as its potential as a regulator of cellular processes, make it an attractive target for small molecules that can inhibit its activity . Further research is needed to determine the full extent of ZBED4's potential as a drug target or biomarker, and to understand its underlying mechanisms of action.

Protein Name: Zinc Finger BED-type Containing 4

Functions: Transcriptional regulator that binds to poly-guanine tracts in gene promoters and activates transcription (By similarity). Able to bind single- and double-stranded DNA and RNA (By similarity)

More Common Targets